Now Available: Final Rule for FDAAA 801 and NIH Policy on Clinical Trial Reporting

Blood Glycan Biomarkers in Women With Stage IV Breast Cancer

This study is ongoing, but not recruiting participants.
Sponsor:
Information provided by (Responsible Party):
University of California, Davis
ClinicalTrials.gov Identifier:
NCT00897962
First received: May 9, 2009
Last updated: January 3, 2017
Last verified: January 2017
No Study Results Posted on ClinicalTrials.gov for this Study
  Study Status: This study is ongoing, but not recruiting participants.
  Estimated Study Completion Date: December 2017
  Primary Completion Date: February 2011 (Final data collection date for primary outcome measure)